GlassScriptPhysician profile
Matthew Philippi
NPI 1245791714
$6,844.33
in general payments reported to CMS, 2019-2025
9 companies · $3,756 in 2025
The $3,756 reported for 2025 was more than what 79% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $148 · 2023: $15.70 · 2024: $2,925 · 2025: $3,756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,318 · Food and Beverage: $2,146 · Education: $232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,318.26 |
| Food and Beverage | $2,146.40 |
| Education | $231.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,710.20 | 2023-2025 | Everest Spinal System, Aero-Ll, Niagara Lateral Access System |
| Globus Medical, INC. | $2,193.26 | 2024-2025 | Mars, Excelsius Gps, Prone Lateral |
| Synthes Gmbh | $1,070.86 | 2024 | |
| Medtronic, INC. | $259.36 | 2022-2024 | Aquamantys(Tm) |
| Vb Spine LLC | $240.30 | 2025 | Escalate, Canyon Retractor Systems, Caspian Spinal System |
| Spineology INC. | $224.14 | 2025 | |
| Depuy Synthes Sales INC. | $113.29 | 2024-2025 | Viper, Expedium Verse, Conduit |
| Highridge Medical LLC | $18.44 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Boston Scientific Corporation | $14.48 | 2025 | General - Pain Management |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Philippi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.